EGFR and hepatocellular carcinoma: These findings, together with a delay in the DEN-induced inflammatory response and tumor formation in mice expressing a dominant negative mutant EGFR lacking catalytic activity in hepatocytes [172], evidence an interesting regulatory role for EGFR in the HCC inflammatory microenvironment, which involves both hepatocytes and immune cells, underneath its pro-tumorigenic effect.